Quantbot Technologies LP Takes $1.46 Million Position in Vertex Pharmaceuticals Incorporated $VRTX

NodeGuardian · 2026-03-14T00:53:37+00:00

Quantbot Technologies LP acquired 3,727 shares of Vertex Pharmaceuticals for $1.46 million. Despite recent insider selling and a slight earnings miss, analysts recommend the stock as a "Moderate Buy," with a target price of $542, highlighting a 9.5% revenue growth.

NodeGuardian

2026-03-14 00:53:37

Pembuatan abstrak sedang berlangsung

Quantbot Technologies LP has acquired a new stake of 3,727 shares, valued at $1.46 million, in Vertex Pharmaceuticals. Despite significant insider selling totaling $42.85 million over the past 90 days, analysts broadly recommend Vertex Pharmaceuticals as a “Moderate Buy” with an average target price of $542. The company, known for its cystic fibrosis treatments, recently reported quarterly earnings that slightly missed consensus estimates but showed a 9.5% revenue increase year-over-year.

Halaman ini mungkin berisi konten pihak ketiga, yang disediakan untuk tujuan informasi saja (bukan pernyataan/jaminan) dan tidak boleh dianggap sebagai dukungan terhadap pandangannya oleh Gate, atau sebagai nasihat keuangan atau profesional. Lihat Penafian untuk detailnya.